Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

INSM

Insmed Inc

Mar 13 • 04:00PM ET

75.07

Dollar change +1.03
Percentage change 1.39	%

Healthcare • Biotechnology • USA • NASD

Peers: VRTX BIIB REGN GILD RARE NBIX UTHR SRPT EXEL BMRN

| Held by: VTI VB IWM VXF VBK XBI IWO IBB VTWO VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-5.59	Insider Own	2.34%	Shs Outstand	179.38M	Perf Week	0.07%
Market Cap	13.59B	Forward P/E	-	EPS next Y	-3.70	Insider Trans	-15.53%	Shs Float	176.77M	Perf Month	-6.03%
Income	-913.77M	PEG	-	EPS next Q	-1.35	Inst Own	106.99%	Short Float	8.27%	Perf Quarter	3.16%
Sales	363.71M	P/S	37.36	EPS this Y	8.11%	Inst Trans	2.72%	Short Ratio	7.56	Perf Half Y	4.89%
Book/sh	1.59	P/B	47.19	EPS next Y	27.76%	ROA	-54.47%	Short Interest	14.62M	Perf Year	177.22%
Cash/sh	7.92	P/C	9.48	EPS next 5Y	58.96%	ROE	-890.75%	52W Range	21.92 - 84.91	Perf YTD	8.73%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-13.12%	ROI	-57.72%	52W High	-11.59%	Beta	1.09
Dividend TTM	-	Quick Ratio	5.12	Sales past 5Y	21.77%	Gross Margin	75.04%	52W Low	242.47%	ATR (14)	3.13
Dividend Ex-Date	-	Current Ratio	5.45	EPS Y/Y TTM	-4.45%	Oper. Margin	-216.26%	RSI (14)	44.92	Volatility	3.88% 4.24%
Employees	1271	Debt/Eq	4.60	Sales Y/Y TTM	19.17%	Profit Margin	-251.24%	Recom	1.06	Target Price	97.44
Option/Short	Yes / Yes	LT Debt/Eq	4.55	EPS Q/Q	-2.40%	Payout	-	Rel Volume	0.61	Prev Close	74.04
Sales Surprise	2.31%	EPS Surprise	-12.74%	Sales Q/Q	24.79%	Earnings	Feb 20 BMO	Avg Volume	1.93M	Price	75.07
SMA20	-3.81%	SMA50	-1.02%	SMA200	4.12%	Trades		Volume	1,186,555	Change	1.39%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-25-25	Initiated	RBC Capital Mkts	Outperform	$100
Apr-23-24	Initiated	Truist	Buy	$48
Feb-15-24	Initiated	Wolfe Research	Outperform	$42
Dec-08-23	Initiated	Wells Fargo	Overweight	$55
Nov-20-23	Resumed	JP Morgan	Overweight	$36
Jul-26-23	Initiated	Guggenheim	Buy	$50
Dec-09-22	Initiated	Mizuho	Buy	$28
Dec-07-22	Initiated	Barclays	Overweight	$37
Nov-18-22	Initiated	BofA Securities	Buy	$39
Apr-27-22	Initiated	Goldman	Buy	$56
Dec-06-21	Initiated	JP Morgan	Overweight	$45
Oct-19-21	Resumed	Morgan Stanley	Overweight	$56 → $52
Oct-19-21	Resumed	Monness Crespi & Hardt	Buy	$52
Oct-08-21	Initiated	Cantor Fitzgerald	Overweight	$60
Apr-26-21	Resumed	Credit Suisse	Outperform	$60
Dec-17-20	Initiated	Berenberg	Buy	$48
Oct-12-20	Resumed	Stifel	Buy	$44
Sep-03-19	Initiated	Goldman	Buy	$30
Apr-09-19	Reiterated	H.C. Wainwright	Buy	$43 → $52
Feb-15-19	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform	$40

Show Previous Ratings

Mar-10-25 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Feb-24-25 09:15AM	International Markets and Insmed (INSM): A Deep Dive for Investors (Zacks)
08:00AM	Insmed Announces that FDA Does Not Currently Plan to Hold Advisory Committee Meeting to Discuss New Drug Application for Brensocatib in Patients with Bronchiectasis (PR Newswire)
Feb-21-25 02:04AM	Insmed Inc (INSM) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com)
Feb-20-25 09:30AM	Insmed (INSM) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
08:15AM	Loading…
08:15AM	Insmed (INSM) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:20AM	Insmed: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	Insmed Reports Fourth-Quarter and Full-Year 2024 Financial Results and Provides Business Update (PR Newswire)
Feb-19-25 09:50AM	Will Insmed Incorporateds (INSM) New Drugs be Able to Peak Sales? (Insider Monkey)
Feb-17-25 09:16AM	Countdown to Insmed (INSM) Q4 Earnings: Wall Street Forecasts for Key Metrics (Zacks)
Feb-13-25 10:01AM	Insmed (INSM) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release (Zacks)
Feb-11-25 08:00AM	Insmed To Present at March 2025 Investor Conferences (PR Newswire)
Feb-10-25 08:00AM	Insmed to Host Fourth-Quarter and Full-Year 2024 Financial Results Conference Call on Thursday, February 20, 2025 (PR Newswire)
Feb-07-25 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Feb-06-25 08:00AM	FDA Grants Priority Review to Insmed's Brensocatib for Treatment of Bronchiectasis with PDUFA Target Action Date Set for August 12, 2025 (PR Newswire)
03:00AM	Loading…
Jan-24-25 03:00AM	Gene therapies have been uneven for DMD but these companies hope to turn the tide (Pharma Voice)
Jan-18-25 05:46PM	Is Insmed Incorporated (INSM) One of the Best Russell 2000 Stocks to Invest in According to Analysts? (Insider Monkey)
Jan-15-25 12:29PM	Insmeds gene therapy poised to challenge DMD landscape after IND clearance (Pharmaceutical Technology)
Jan-13-25 03:06PM	Why INSM Stock Is Advancing Today (Insider Monkey) +5.64%
Jan-10-25 08:00AM	Insmed Provides Business Update at 43rd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Jan-03-25 04:05PM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Jan-02-25 08:00AM	Insmed To Present at the 43rd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Jan-01-25 09:40AM	Why Is Insmed Incorporated (INSM) Among the Best Multibagger Stocks to Buy Right Now? (Insider Monkey)
Dec-23-24 10:33AM	Is Insmed Incorporated (INSM) the Best Performing Biotech Stock in 2024? (Insider Monkey)
Dec-09-24 07:51AM	Should You Invest in Insmed Incorporated (INSM)? (Insider Monkey)
Dec-06-24 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Dec-02-24 02:35PM	Why Is Insmed Incorporated (INSM) Among the Best High Growth Healthcare Stocks to Invest In Now? (Insider Monkey)
08:00AM	Insmed To Present at December 2024 Investor Conferences (PR Newswire)
Nov-07-24 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Nov-06-24 08:00AM	Insmed To Present at November 2024 Investor Conferences (PR Newswire) +5.14%
09:15AM	Loading…
Nov-04-24 09:15AM	Insmed (INSM) Reliance on International Sales: What Investors Need to Know (Zacks)
Nov-01-24 09:22AM	Do You Believe in the Growth Potential of Insmed (INSM)? (Insider Monkey)
03:03AM	Insmed Inc (INSM) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
01:58AM	Q3 2024 Insmed Inc Earnings Call (Thomson Reuters StreetEvents)
01:12AM	Decoding Insmed Inc (INSM): A Strategic SWOT Insight (GuruFocus.com)
Oct-31-24 10:00AM	Insmed (INSM) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
08:15AM	Insmed (INSM) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
07:17AM	Insmed: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	Insmed Reports Third-Quarter 2024 Financial Results and Provides Business Update (PR Newswire)
Oct-30-24 09:15AM	Insmed (INSM) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates (Zacks)
Oct-29-24 05:47PM	How to play biotech stocks: Insmed and Wave Life Sciences (Yahoo Finance Video)
Oct-24-24 04:05PM	Insmed Ranks No. 1 on Science's 2024 Top Biopharma Employers List (PR Newswire)
Oct-23-24 08:00AM	Insmed Unites Across Communities Around the World During Third Annual Global Day of Good (PR Newswire)
Oct-17-24 10:01AM	Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
08:00AM	Insmed to Host Third-Quarter 2024 Financial Results Conference Call on Thursday, October 31, 2024 (PR Newswire)
Oct-09-24 05:28PM	Insmed Inc (INSM) Q2 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com)
Oct-08-24 04:05PM	New Subgroup Analyses from Landmark Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis Demonstrate Consistency with Positive Overall Trial Population Results (PR Newswire)
Oct-06-24 09:23AM	Insmed Inc. (INSM): Hedge Funds Are Bullish On This NASDAQ Stock Right Now (Insider Monkey)
Oct-04-24 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Sep-29-24 06:38AM	Is Insmed Incorporated (INSM) the Best Performing Long Term Stock in 2024? (Insider Monkey)
Sep-26-24 12:25AM	Is Insmed Inc. (INSM) the Best Performing Stock in 2024? (Insider Monkey)
Sep-21-24 10:14AM	Insmed Inc. (INSM): A Top Mid-Cap Biopharma Stock with Compelling Growth Potential (Insider Monkey)
Sep-11-24 05:45AM	Insmed Incorporated (INSM) Surged Following Positive Data For its Drug (Insider Monkey)
Sep-08-24 01:52AM	Insmed Incorporated (INSM): Hedge Funds Are Recommending This Biotech Stock Now (Insider Monkey)
Sep-06-24 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Aug-29-24 03:30AM	Insmed (INSM) Rose Due to Positive Trial Results (Insider Monkey)
Aug-24-24 02:29PM	Analyst Thinks Marvell Technology (MRVL) Will Benefit from Nvidia's Blackwell Launch (Insider Monkey)
08:00AM	Meta Stock Leads 5 Names Near Buy Points As Market Bounces (Investor's Business Daily)
Aug-14-24 07:01PM	Insider Sale: Chief People Strategy Officer Schaeffer Orlov S Nicole Sells Shares of Insmed Inc ... (GuruFocus.com)
Aug-09-24 11:41AM	Insmed (INSM) Lags on Q2 Earnings, Tops Sales, Reiterates View (Zacks)
01:07AM	Decoding Insmed Inc (INSM): A Strategic SWOT Insight (GuruFocus.com)
Aug-08-24 09:30AM	Compared to Estimates, Insmed (INSM) Q2 Earnings: A Look at Key Metrics (Zacks)
08:10AM	Insmed (INSM) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
07:08AM	Insmed: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	Insmed Reports Second-Quarter 2024 Financial Results and Provides Business Update (PR Newswire)
Aug-02-24 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Jul-29-24 08:00AM	Insmed to Host Second-Quarter 2024 Financial Results Conference Call on Thursday, August 8, 2024 (PR Newswire)
Jul-25-24 06:39PM	These Signs Show Which Stocks Are Having A Hidden Rally, Says Mark Minervini (Investor's Business Daily)
10:02AM	Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Jul-16-24 08:28AM	Should You Consider Adding Marvell Technology (MRVL) to Your Portfolio? (Insider Monkey)
07:48AM	What Makes Insmed Incorporated (INSM) a Prospective Investment? (Insider Monkey)
06:43AM	Is CCC Intelligent Solutions Holdings (CCCS) a Worthy Stock to Add? (Insider Monkey)
Jul-05-24 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire) +12.90%
Jul-03-24 11:53AM	More endpoints met in Insmeds Phase III brensocatib trial (Clinical Trials Arena)
09:03AM	Additional Positive Data from Pivotal ASPEN Study of Brensocatib in Patients with Bronchiectasis to be Presented at the 7th World Bronchiectasis Conference (PR Newswire)
Jul-02-24 11:53AM	Pharma companies shape competitive pipeline for bronchiectasis (Clinical Trials Arena)
Jun-27-24 08:00AM	Insmed Announces Redemption of all $225 Million of Outstanding 1.75% Convertible Senior Notes Due 2025 (PR Newswire)
Jun-14-24 07:50AM	Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing (BioPharma Dive)
Jun-07-24 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Jun-05-24 08:00AM	Insmed To Present at the Goldman Sachs 45th Annual Global Healthcare Conference (PR Newswire)
Jun-04-24 06:00AM	The 3 Most Undervalued Biotech Stocks to Buy in June 2024 (InvestorPlace)
May-30-24 04:05PM	Insmed to Host Commercial Webinar on June 4, 2024 (PR Newswire) +6.41%
08:00AM	Insmed Announces Pricing of $650 Million Public Offering of Common Stock (PR Newswire)
May-29-24 12:20PM	Insmed (INSM) Stock Soars 118% on Upbeat Lung Disease Drug Data (Zacks) +11.42%
06:05AM	Insmed stocks soar as Phase III lung disease drug exceeds expectations (Clinical Trials Arena)
May-28-24 07:25PM	Insmed CEO on lung disease treatment and path forward (CNBC TV) +118.45%
06:21PM	Insmed Announces Proposed $500 Million Public Offering of Common Stock (PR Newswire)
04:49PM	Insmed Stock More Than Doubled in Value Tuesday Here's Why (Investopedia)
04:02PM	The Next Humira? Insmed Catapults 119% On Its 'Very Attractive' Opportunity In Lung Disease. (Investor's Business Daily)
03:41PM	Insmed stock blasts off over lung condition study results (Yahoo Finance Video)
02:24PM	Chart of the Day: Insmed (CNBC TV)
02:21PM	Insmed Stock Surges on Trial Win for Lung-Condition Drug. We Hit the Mark, CEO Says. (Barrons.com)
01:16PM	Stocks to Watch Tuesday: GameStop, Apple, Nvidia, Hess (The Wall Street Journal)
12:20PM	Insmed, Agios rise; DraftKings, Atlantica fall, Tuesday, 5/28/2024 (Associated Press Finance)
10:58AM	Why Is Inflammatory Diseased-Focused Insmed Stock Soaring On Tuesday? (Benzinga)
10:01AM	Insmed's shares double as lung disease med powers past expectations in phase 3 (FierceBiotech.com)
09:36AM	Insmed Shares Rocket After Drug Eases Lung Disease Symptoms (Bloomberg)
09:04AM	Insmed Catapults 128% After Proving Its Theory In A 'Large, Untapped' Lung Disease Market (Investor's Business Daily)
09:00AM	Insmed Stock More Than Doubles on Trial Win for Lung-Condition Drug (Barrons.com)
08:40AM	Why Is Insmed (INSM) Stock Up 134% Today? (InvestorPlace)

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Lewis William	Chair and CEO	Mar 03 '25	Option Exercise	22.76	18,750	426,750	352,936	Mar 05 05:27 PM
Lewis William	Chair and CEO	Mar 03 '25	Option Exercise	10.85	6,830	74,106	240,754	Mar 05 05:27 PM
Lewis William	Chair and CEO	Mar 03 '25	Sale	77.79	18,750	1,458,519	334,186	Mar 05 05:27 PM
Lewis William	Chair and CEO	Mar 03 '25	Sale	77.79	6,830	531,278	233,924	Mar 05 05:27 PM
Lewis William	Officer	Mar 03 '25	Proposed Sale	77.75	25,580	1,988,965		Mar 03 05:53 PM
Lewis William	Chair and CEO	Feb 18 '25	Option Exercise	22.76	18,750	426,750	352,936	Feb 20 04:52 PM
Lewis William	Chair and CEO	Feb 18 '25	Option Exercise	10.85	6,830	74,106	240,754	Feb 20 04:52 PM
Lewis William	Chair and CEO	Feb 18 '25	Sale	81.03	18,750	1,519,279	334,186	Feb 20 04:52 PM
Lewis William	Chair and CEO	Feb 18 '25	Sale	81.03	6,830	553,442	233,924	Feb 20 04:52 PM
Bonstein Sara	Chief Financial Officer	Feb 18 '25	Sale	80.31	18,322	1,471,394	118,863	Feb 20 04:52 PM
Lewis William	Officer	Feb 18 '25	Proposed Sale	81.00	25,580	2,071,913		Feb 18 05:31 PM
Bonstein Sara	Chief Financial Officer	Feb 11 '25	Sale	80.00	13,302	1,064,160	142,204	Feb 13 05:09 PM
Bonstein Sara	Chief Financial Officer	Feb 12 '25	Sale	80.00	5,019	401,520	137,185	Feb 13 05:09 PM
Adsett Roger	Chief Operating Officer	Feb 10 '25	Sale	78.61	42,975	3,378,067	146,082	Feb 12 04:45 PM
Flammer Martina M.D.	Chief Medical Officer	Feb 10 '25	Sale	78.61	37,828	2,973,485	100,165	Feb 12 04:45 PM
Bonstein Sara	Officer	Feb 11 '25	Proposed Sale	80.00	36,643	2,931,440		Feb 11 04:42 PM
Flammer Martina M.D.	Officer	Feb 10 '25	Proposed Sale	78.57	37,828	2,972,328		Feb 10 04:52 PM
Adsett Roger	Officer	Feb 10 '25	Proposed Sale	78.57	42,975	3,376,752		Feb 10 04:45 PM
Flammer Martina M.D.	Chief Medical Officer	Feb 06 '25	Sale	80.90	33,055	2,674,150	138,053	Feb 07 05:11 PM
Flammer Martina M.D.	Chief Medical Officer	Feb 07 '25	Sale	79.59	60	4,775	137,993	Feb 07 05:11 PM
Schaeffer Orlov S Nicole	Chief People Strategy Officer	Feb 06 '25	Sale	80.90	23,500	1,901,150	120,878	Feb 07 05:11 PM
Adsett Roger	Chief Operating Officer	Feb 06 '25	Sale	80.90	45,605	3,689,445	189,157	Feb 07 05:11 PM
Adsett Roger	Chief Operating Officer	Feb 07 '25	Sale	79.57	100	7,957	189,057	Feb 07 05:11 PM
Lewis William	Chair and CEO	Feb 06 '25	Sale	80.90	79,350	6,419,415	453,894	Feb 07 05:11 PM
Wise John Drayton	Chief Commercial Officer	Feb 06 '25	Sale	80.90	7,910	639,919	133,025	Feb 07 05:11 PM
Wise John Drayton	Chief Commercial Officer	Feb 07 '25	Sale	78.91	10	789	133,015	Feb 07 05:11 PM
Bonstein Sara	Chief Financial Officer	Feb 06 '25	Sale	80.90	28,390	2,296,751	155,506	Feb 07 05:10 PM
Smith Michael Alexander	Chief Legal Officer	Feb 06 '25	Sale	80.90	20,650	1,670,585	96,610	Feb 07 05:10 PM
Wise John Drayton	Officer	Feb 06 '25	Proposed Sale	80.90	8,000	647,200		Feb 06 05:56 PM
Smith Michael Alexander	Officer	Feb 06 '25	Proposed Sale	80.90	21,000	1,698,900		Feb 06 05:43 PM
Schaeffer Orlov S Nicole	Officer	Feb 06 '25	Proposed Sale	80.90	61,000	4,934,900		Feb 06 05:39 PM
Lewis William	Officer	Feb 06 '25	Proposed Sale	80.90	86,000	6,957,400		Feb 06 05:34 PM
Flammer Martina M.D.	Officer	Feb 06 '25	Proposed Sale	80.90	33,500	2,710,150		Feb 06 05:25 PM
Bonstein Sara	Officer	Feb 06 '25	Proposed Sale	80.90	29,000	2,346,100		Feb 06 05:21 PM
Adsett Roger	Officer	Feb 06 '25	Proposed Sale	80.90	46,000	3,721,400		Feb 06 05:17 PM
Lewis William	Chair and CEO	Feb 03 '25	Option Exercise	22.76	18,750	426,750	398,284	Feb 05 04:44 PM
Lewis William	Chair and CEO	Feb 03 '25	Option Exercise	10.85	6,830	74,106	240,754	Feb 05 04:44 PM
Lewis William	Chair and CEO	Feb 03 '25	Sale	77.94	18,750	1,461,430	379,534	Feb 05 04:44 PM
Lewis William	Chair and CEO	Feb 03 '25	Sale	77.94	6,830	532,301	233,924	Feb 05 04:44 PM
Lewis William	Officer	Feb 03 '25	Proposed Sale	77.91	25,580	1,992,928		Feb 03 04:35 PM
Schaeffer Orlov S Nicole	Chief People Strategy Officer	Jan 30 '25	Option Exercise	15.04	91,140	1,370,384	188,223	Jan 31 04:33 PM
Schaeffer Orlov S Nicole	Chief People Strategy Officer	Jan 30 '25	Sale	80.00	91,140	7,291,200	97,083	Jan 31 04:33 PM
Schaeffer Orlov S Nicole	Officer	Jan 30 '25	Proposed Sale	80.00	91,140	7,291,200		Jan 30 04:28 PM
Flammer Martina M.D.	Chief Medical Officer	Jan 14 '25	Sale	68.72	1,384	95,108	100,165	Jan 16 04:38 PM
Adsett Roger	Chief Operating Officer	Jan 14 '25	Sale	68.72	1,457	100,125	146,082	Jan 16 04:37 PM
Schaeffer Orlov S Nicole	Chief People Strategy Officer	Jan 14 '25	Sale	68.72	872	59,924	97,083	Jan 16 04:37 PM
Lewis William	Chair and CEO	Jan 15 '25	Option Exercise	22.76	18,750	426,750	411,339	Jan 16 04:37 PM
Lewis William	Chair and CEO	Jan 15 '25	Option Exercise	10.85	6,830	74,106	240,754	Jan 16 04:37 PM
Lewis William	Chair and CEO	Jan 15 '25	Sale	70.18	31,805	2,232,161	379,534	Jan 16 04:37 PM
Lewis William	Chair and CEO	Jan 15 '25	Sale	70.17	6,830	479,295	233,924	Jan 16 04:37 PM
Lewis William	Officer	Jan 15 '25	Proposed Sale	70.17	38,635	2,711,017		Jan 15 05:17 PM
Flammer Martina M.D.	Chief Medical Officer	Jan 10 '25	Sale	63.64	6,172	392,813	101,549	Jan 10 06:45 PM
Flammer Martina M.D.	Chief Medical Officer	Jan 07 '25	Sale	65.91	3,344	220,403	102,766	Jan 10 06:45 PM
Flammer Martina M.D.	Chief Medical Officer	Jan 08 '25	Sale	66.16	1,702	112,604	101,064	Jan 10 06:45 PM
Bonstein Sara	Chief Financial Officer	Jan 07 '25	Sale	65.70	3,470	227,979	114,736	Jan 10 06:45 PM
Bonstein Sara	Chief Financial Officer	Jan 08 '25	Sale	66.05	1,464	96,697	113,272	Jan 10 06:45 PM
Bonstein Sara	Chief Financial Officer	Jan 10 '25	Sale	63.72	1,066	67,926	118,863	Jan 10 06:45 PM
Schaeffer Orlov S Nicole	Chief People Strategy Officer	Jan 10 '25	Sale	63.68	4,057	258,348	97,955	Jan 10 06:45 PM
Schaeffer Orlov S Nicole	Chief People Strategy Officer	Jan 07 '25	Sale	65.88	2,596	171,024	97,515	Jan 10 06:45 PM
Schaeffer Orlov S Nicole	Chief People Strategy Officer	Jan 08 '25	Sale	65.84	1,209	79,601	96,306	Jan 10 06:45 PM
Wise John Drayton	Chief Commercial Officer	Jan 07 '25	Option Exercise	16.07	10,000	160,700	132,492	Jan 10 06:45 PM
Wise John Drayton	Chief Commercial Officer	Jan 07 '25	Sale	65.96	12,908	851,350	119,584	Jan 10 06:45 PM
Wise John Drayton	Chief Commercial Officer	Jan 08 '25	Sale	66.21	392	25,954	119,192	Jan 10 06:45 PM
Wise John Drayton	Chief Commercial Officer	Jan 10 '25	Sale	65.40	287	18,770	125,562	Jan 10 06:45 PM
Lewis William	Chair and CEO	Jan 07 '25	Sale	66.02	8,218	542,552	376,742	Jan 10 06:44 PM
Lewis William	Chair and CEO	Jan 08 '25	Sale	65.96	3,999	263,774	372,743	Jan 10 06:44 PM
Lewis William	Chair and CEO	Jan 10 '25	Sale	63.36	2,978	188,686	392,589	Jan 10 06:44 PM
Smith Michael Alexander	Chief Legal Officer	Jan 07 '25	Sale	65.98	2,306	152,150	65,642	Jan 10 06:44 PM
Smith Michael Alexander	Chief Legal Officer	Jan 08 '25	Sale	66.21	1,064	70,447	64,578	Jan 10 06:44 PM
Smith Michael Alexander	Chief Legal Officer	Jan 10 '25	Sale	63.38	319	20,218	69,965	Jan 10 06:44 PM
Adsett Roger	Chief Operating Officer	Jan 10 '25	Sale	63.68	4,902	312,177	147,539	Jan 10 06:44 PM
Adsett Roger	Chief Operating Officer	Jan 07 '25	Sale	65.95	2,444	161,182	147,666	Jan 10 06:44 PM
Adsett Roger	Chief Operating Officer	Jan 08 '25	Sale	66.10	1,882	124,400	145,784	Jan 10 06:44 PM
Adsett Roger	Officer	Jan 10 '25	Proposed Sale	64.50	5,061	326,434		Jan 10 06:11 PM
Schaeffer Orlov S Nicole	Officer	Jan 10 '25	Proposed Sale	64.50	3,964	255,678		Jan 10 06:01 PM
Flammer Martina M.D.	Officer	Jan 10 '25	Proposed Sale	64.50	6,185	398,932		Jan 10 05:53 PM
Bonstein Sara	Officer	Jan 10 '25	Proposed Sale	63.72	1,066	67,926		Jan 10 05:45 PM
Flammer Martina M.D.	Officer	Jan 10 '25	Proposed Sale	63.73	1,371	87,380		Jan 10 05:42 PM
Adsett Roger	Officer	Jan 10 '25	Proposed Sale	63.86	1,298	82,884		Jan 10 05:38 PM
Smith Michael Alexander	Officer	Jan 10 '25	Proposed Sale	63.38	319	20,218		Jan 10 05:31 PM
Wise John Drayton	Officer	Jan 10 '25	Proposed Sale	65.40	287	18,769		Jan 10 05:19 PM
Schaeffer Orlov S Nicole	Officer	Jan 10 '25	Proposed Sale	63.86	965	61,629		Jan 10 05:16 PM
Lewis William	Officer	Jan 10 '25	Proposed Sale	63.34	2,978	188,636		Jan 10 05:09 PM
Bonstein Sara	Officer	Jan 08 '25	Proposed Sale	66.04	1,464	96,682		Jan 08 05:31 PM
Flammer Martina M.D.	Officer	Jan 08 '25	Proposed Sale	66.15	1,702	112,587		Jan 08 05:26 PM
Adsett Roger	Officer	Jan 08 '25	Proposed Sale	66.10	1,882	124,400		Jan 08 05:17 PM
Smith Michael Alexander	Officer	Jan 08 '25	Proposed Sale	66.21	1,064	70,447		Jan 08 04:57 PM
Wise John Drayton	Officer	Jan 08 '25	Proposed Sale	66.21	392	25,954		Jan 08 04:52 PM
Schaeffer Orlov S Nicole	Officer	Jan 08 '25	Proposed Sale	65.84	1,209	79,600		Jan 08 04:47 PM
Lewis William	Officer	Jan 08 '25	Proposed Sale	65.95	3,999	263,734		Jan 08 04:39 PM
Bonstein Sara	Officer	Jan 07 '25	Proposed Sale	66.11	3,470	229,401		Jan 07 06:03 PM
Flammer Martina M.D.	Officer	Jan 07 '25	Proposed Sale	65.91	3,344	220,388		Jan 07 05:54 PM
Adsett Roger	Officer	Jan 07 '25	Proposed Sale	66.11	2,444	161,572		Jan 07 05:45 PM
Smith Michael Alexander	Officer	Jan 07 '25	Proposed Sale	65.98	2,306	152,148		Jan 07 05:36 PM
Wise John Drayton	Officer	Jan 07 '25	Proposed Sale	65.95	10,000	659,481		Jan 07 05:22 PM
Wise John Drayton	Officer	Jan 07 '25	Proposed Sale	65.87	2,908	191,544		Jan 07 05:17 PM
Schaeffer Orlov S Nicole	Officer	Jan 07 '25	Proposed Sale	65.88	2,596	171,027		Jan 07 05:10 PM
Lewis William	Officer	Jan 07 '25	Proposed Sale	66.01	8,218	542,510		Jan 07 04:56 PM
Lewis William	Chair and CEO	Jan 02 '25	Option Exercise	22.76	18,750	426,750	403,710	Jan 03 06:52 PM
Lewis William	Chair and CEO	Jan 02 '25	Option Exercise	10.85	6,830	74,106	240,754	Jan 03 06:52 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

INSM

Insmed Inc

Upgrade your FINVIZ experience